Having finalised a PET-RF insert for precision imaging of breast cancer, the achievements of the HYPMED project were presented in an online session “Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer” at the 2022 European Congress of Radiology Overture on 3 March from 16:00-17:00 CET. The session was one of the free sessions, requiring no payment of the ECR registration fee.
The session remains freely available online with the creation of an ESR Connect account. Follow the link below, log in and select the HYPMED session to tune in!
Hosted on ESR Connect, the session opened with an overview by the project's scientific coordinator, Dr. Christiane Kuhl, illustrating the current status and key facts of breast cancer detection and treatment before describing the contribution of HYPMED through combined PET and MR imaging with its PET-MRI RF insert device to improve early prediction and detection. The consortium partners and project objectives were also given.
Dr. Volkmar Schulz discussed the improvements of the HYPMED device to overcome the limitations of PET and MRI for breast cancer screening. The components, operation and performance of the device were also illustrated. Dr. Thomas Helbich followed with a description of the project's handling of whole-body PET-MRI data for clinical comparison to enable more accurate and non-invasive assessment of breast tumours. Phenotypes, biomarkers and tracers were discussed, allowing for a cohort study to compare the HYPMED device with conventional whole-body PET-MRI.
Finally, the three presenters were joined by ESR Chair Dr. Michael Fuchsjäger to elaborate on the project according to audience questions submitted online. Many participants complimented the potential advancement in breast cancer screening and inquired regarding the future use of the device.
The full report describing the session will be available on the Results page following its approval by the EC as deliverable 5.3.
EIBIR Research Session: Digital Hybrid Breast PET/MRI for Enhanced Diagnosis of Breast Cancer
Thursday, March 3, 2022; 16:00-17:00 Streamed online via ESR Connect (1 CME credit)
Chairperson’s introduction - Christiane Kuhl; Aachen/DE
Introduction of the HYPMED device: a dedicated ultra-low-dose, ultra-high-sensitivity, PET-RF insert for clinical 1.5T MRI with integrated vacuum biopsy capability - Volkmar Schulz; Aachen/DE
Comparative whole-body PET/MR data for future clinical comparison study- Thomas H. Helbich; Vienna/AT
How to get HYPMED’s innovation into the clinic - Christiane Kuhl; Aachen/DE